This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.
Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.
Resolved shortages
The following shortages have been resolved and supply has resumed to the Irish market:
| Product | Active Ingredient(s) |
| Cardura XL 4mg Prolonged Release Tablets
PA23355/001/001
Viatris Healthcare Limited | Doxazosin |
| Ciprofloxacin Teva 500mg Film Coated Tablets
(10 and 20 pack)
PA0749/031/003
Teva Pharma B.V | Ciprofloxacin |
| Cymex Cream
PA1986/112/001
Teva B.V. | Various |
| Donepezil Krka 5mg Film Coated Tablets
PA1347/014/003
KRKA, d.d., Novo mesto | Donepezil |
| Fybogel Orange 3.5g Granules
PA0979/009/002
Reckitt Benckiser Ireland Ltd | Ispaghula husks |
| Glycopyrronium Bromide 200 micrograms/ml Solution for Injection
3ml presentation
PA0857/001/001
MercuryPharm Ltd | Glycopyrronium |
| Hytrin 5mg Tablets
PA1142/005/003
Amdipharm Limited | Terazosin |
| Metalyse 50mg Powder and Solvent for Solution for Injection
EU/1/00/169/006
Boehringer Ingelheim International GmbH | Tenecteplase |
| Montelukast Mylan 5mg Chewable Tablets
PA0577/131/002
McDermott Laboratories Ltd., T/A Gerard Laboratories | Montelukast |
| Septrin Forte 160mg/800mg Tablets
PA1691/010/002
Aspen Pharma Trading Limited | Sulfamethoxazole & trimethoprim |
| Simvastatin Teva 40mg Film Coated Tablets
PA0749/052/004
Teva Pharma B.V | Simvastatin |
| Travocort 0.1 + 1% w/w Cream
PA1025/012/001
LEO Pharma A/S | Diflucortolone & isoconazole |
Newly notified shortages
The HPRA has been notified of a shortage of the following products:
| Product | Active Ingredient(s) |
| Canesten 500mg Pessary
PA1410/039/009
Bayer Limited | Clotrimazole |
| Carboplatin-Teva 10mg/ml Concentrate for Solution for Infusion
(600mg presentation)
PA0749/004/001
Teva Pharma B.V. | Carboplatin |
| Donepezil Krka 10mg Film Coated Tablets
PA1347/014/004
KRKA, d.d., Novo mesto | Donepezil |
| Donepezil Teva 10mg Film Coated Tablets
PA0749/194/002
Teva B.V. | Donepezil |
| Dozept 5mg Film Coated Tablets
PA0711/141/001
Rowex Ltd | Donepezil |
| Estradot 37.5 micrograms/24 hours, transdermal patch
PA0896/010/001
Novartis Ireland Limited | Estradiol |
| Estradot 50 micrograms/24 hours, transdermal patch
PA0896/010/002
Novartis Ireland Limited | Estradiol |
| Ipramol Steri-Neb 0.5mg / 2.5mg per 2.5ml Nebuliser Solution
PA1986/082/001
Teva B.V. | Ipratropium & salbutamol |
| Isotretinoin 20mg Soft Capsules
PA0711/312/003
Rowex Ltd | Isotretinoin |
| Klacid 250mg/5ml Granules for Oral Suspension
PA23355/013/006
Viatris Healthcare Limited | Clarithromycin |
| Klacid LA 500mg Modified Release Tablets
PA23355/013/004
Viatris Healthcare Limited | Clarithromycin |
| MacroBID 100mg Prolonged-Release Capsules
PA1142/033/001
Amdipharm Limited | Nitrofurantoin |
| Meptid 200mg Film Coated Tablets
PA0968/005/002
Almirall, S.A. | Meptazinol |
| Olmesartan/Amlodipine Clonmel 40 mg/10mg Film Coated Tablets
PA0126/293/003
Clonmel Healthcare Ltd | Olmesartan |
| Rosuvastatin Teva Pharma 10mg Tablets
PA1986/024/002
Teva B.V. | Rosuvastatin |
| Tamnic 400 micrograms Modified-Release Capsules, hard
PA0126/151/001
Clonmel Healthcare Ltd | Tamsulosin |
| Temgesic 200 microgram Sublingual Tablets
PA23460/001/001
Eumedica Pharmaceuticals GmbH | Buprenorphine |
| Testogel 50mg transdermal gel in sachet
PA1054/002/002
Laboratoires Besins International | Testosterone |
| Tolura 40mg Tablets
EU/1/10/632/009
KRKA, d.d., Novo mesto | Telmisartan |
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.